FNB vs UBSI

FNB presents a stark contrast between deep value and deteriorating financial health, highlighted by a weak Piotroski F-Score of 2/9. While the stock is significantly undervalued relative to its Graham Number ($26.4) and Intrinsic Value ($47.79), and trades below book value (P/B 0.92), the deterministic health markers are concerning. Strong YoY earnings growth (18.8%) and a consistent track record of earnings beats provide a bullish fundamental backdrop, but these are offset by bearish insider sentiment and a complete lack of technical momentum. The overall outlook is neutral as the value proposition is currently fighting against poor operational health signals.

UBSI presents a stark contradiction between strong valuation and deteriorating fundamental health. While the stock trades significantly below its Graham Number ($56.24) and Intrinsic Value ($105.31), the Piotroski F-Score of 2/9 indicates severe weakness in financial health and operational efficiency. Despite impressive YoY earnings growth of 50.80% and consistent earnings beats, the bearish technical trend (10/100) and low insider sentiment suggest significant underlying risks that offset the attractive valuation.